Seelos Therapeutics, Inc. (SEELQ) — Cash Flow Quality Index

Latest as of June 2024: -0.57x

Seelos Therapeutics, Inc. (SEELQ) has a Cash Flow Quality Index of -0.57x as of June 2024. Operating cash flow of $-972.00K is below net income of $1.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Seelos Therapeutics, Inc. assets under control for the complete picture of this company's asset base.

Cash Flow Quality Index

-0.57x
Operating CF / Net Income

Operating Cash Flow

$-972.00K
USD

Net Income

$1.71 Million
USD

Data as of

Jun 2024
Most recent filing

Annual Cash Flow Quality Index for Seelos Therapeutics, Inc. (None–None)

Year-by-year earnings quality comparison for Seelos Therapeutics, Inc.. For live market cap and the full company financial profile, see how much is Seelos Therapeutics, Inc. worth.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.